Ikgdar 100mg Injection
Marketer
Cipla Ltd
Salt Composition
Rituximab (100mg)
Overview Ikgdar 100mg Injection
Rituximab 100mg Injection treats various conditions, including non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis, and microscopic polyangiitis. Administered intravenously under medical supervision, dosage and frequency are determined by your physician based on your specific condition and may vary. Strictly adhere to your prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue use only under your doctor's instruction. Common side effects include headache, fatigue, swelling, infections, and alopecia. This medication can lower blood cell counts, increasing infection risk, necessitating regular blood tests, including hepatitis B monitoring. Inform your physician of any pre-existing heart or liver conditions, upcoming surgeries or vaccinations, or concurrent medications, especially those for infections, before commencing treatment. Interactions with other drugs are possible; disclose all medications to your doctor. Use is contraindicated during pregnancy and lactation; effective contraception is crucial for both partners throughout treatment. A patient support program exists in India, managed by Tata 1mg; inquire with your doctor or call (1800-102-1618) for details.
Uses of Ikgdar 100mg Injection
Chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and non-Hodgkin's lymphoma.
Major Benefits of Ikgdar 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ikgdar 100mg Injection:
- Headache
- Weakness
- Infection
- Chills
- Decreased white blood cell count (neutrophils)
- Fever
- Infusion site reaction
- Lymphopenia
- Abdominal pain
- Back pain
How to use Ikgdar 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ikgdar 100mg Injection works:
Ikgdar 100mg injection is a targeted therapy utilizing monoclonal antibodies. Its mechanism involves neutralizing the aberrant function of B lymphocytes, offering therapeutic benefit in rheumatoid arthritis and specific malignancies.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Ikgdar 100mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Ikgdar 100mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Ikgdar 100mg Injection without significant risk to their infants. Available human data indicates minimal danger to the baby.
DrivingCONSULT YOUR DOCTOR
The impact of Ikgdar 100mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Ikgdar 100mg Injection appears to pose minimal risk for individuals with impaired kidney function. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Ikgdar 100mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised. Ikgdar 100mg Injection is contraindicated for patients experiencing active liver disease or a history of viral hepatitis due to the potential for infection recurrence.
What if you forget to take Ikgdar 100mg Injection :
Omit a dose of Ikgdar 100mg Injection? Seek your physician's advice.
Facts to Know About Ikgdar 100mg Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Action Category | Anti-CD20 Therapy |
3,018 People bought this recently